TrialJAMA oncology2022

Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial.

Matthew H G Katz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.